Recombinant Endostatin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Endostatin, covering 2017-04-17 to 2017-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer [Phase 3]